Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?

Life Sciences

Volumn 97, Issue 1, 2014, Pages 45-54

  Fantegrossi, William E ^a   Moran, Jeffery H ^a,b   Radominska Pandya, Anna ^a   Prather, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Public Health Laboratory   (United States)

Author keywords

9 Tetrahydrocannabinol; CB1 receptors; CB2 receptors; Drug abuse; Drug metabolism; K2 Spice; Synthetic cannabis

Indexed keywords

CB1 RECEPTORS; CB2 RECEPTORS; DRUG ABUSE; DRUG METABOLISM; K2/SPICE; SYNTHETIC CANNABIS; Δ(9)-TETRAHYDROCANNABINOL;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; CANNABINOIDS; DESIGNER DRUGS; DRONABINOL; HUMANS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; STREET DRUGS;

EID: 84894041500     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.09.017     Document Type: Review

References (118)

1. M.D. Aceto, S.M. Scates, and B.B. Martin Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2 Eur J Pharmacol 416 2001 75 81 (Pubitemid 32244437)
2. I.B. Adams, and B.R. Martin Cannabis: pharmacology and toxicology in animals and humans Addiction 91 1996 1585 1614 (Pubitemid 26393422)
3. D.J. Allsop, M.M. Norberg, J. Copeland, S. Fu, and A.J. Budney The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress Drug Alcohol Depend 119 2011 123 129
4. B.K. Atwood, J. Huffman, A. Straiker, and K. Mackie JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist Br J Pharmacol 160 2010 585 593
5. B.K. Atwood, D. Lee, A. Straiker, T.S. Widlanski, and K. Mackie CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists Eur J Pharmacol 659 2011 139 145
6. M.M. Aung, G. Griffin, J.W. Huffman, M. Wu, C. Keel, and B. Yang et al. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding Drug Alcohol Depend 60 2000 133 140 (Pubitemid 30625016)
7. R.L. Balster, and W.R. Prescott Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Neurosci Biobehav Rev 16 1992 55 62
8. S. Beuck, I. Moller, A. Thomas, A. Klose, N. Schlorer, and W. Schanzer et al. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing Anal Bioanal Chem 401 2011 493 505
9. L.M. Bornheim, J.M. Lasker, and J.L. Raucy Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol Drug Metab Dispos 20 1992 241 246
10. L.K. Brents, A. Gallus-Zawada, A. Radominska-Pandya, T. Vasiljevik, T.E. Prisinzano, and W.E. Fantegrossi et al. Mono-hydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity Biochem Pharmacol 83 2012 952 961
11. L.K. Brents, E.E. Reichard, S.M. Zimmerman, J.H. Moran, W.E. Fantegrossi, and P.L. Prather Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity PLoS One 6 2011 c21917
12. L.K. Brents, S.M. Zimmerman, A.R. Saffell, P.L. Prather, and W.E. Fantegrossi Differential drug-drug interactions of the synthetic cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy J Pharmacol Exp Ther 346 2013 350 361
13. A.L. Bretteville-Jensen, S.S. Tuv, O.R. Bilgrei, B. Fjeld, and L. Bachs Synthetic cannabinoids and cathinones: prevalence and markets Forensic Sci Rev 25 2013 7 26
14. K.C. Chimalakonda, S.M. Bratton, V.H. Le, K.H. Yiew, A. Dineva, and C.L. Moran et al. Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases Drug Metab Dispos 39 2011 1967 1976
15. K.C. Chimalakonda, C.L. Moran, P.D. Kennedy, G.W. Endres, A. Uzieblo, and P.J. Dobrowolski et al. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine Anal Chem 83 2011 6381 6388
16. K.C. Chimalakonda, K.A. Seely, S.M. Bratton, L.K. Brents, C.L. Moran, and G.W. Endres et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands Drug Metab Dispos 40 2012 2174 2184
17. C.N. Chin, J.W. Murphy, J.W. Huffman, and D.A. Kendall The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor J Pharmacol Exp Ther 291 1999 837 844 (Pubitemid 29503560)
18. D.R. Compton, M.R. Johnson, L.S. Melvin, and B.R. Martin Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents J Pharmacol Exp Ther 260 1992 201 209
19. C. Coulter, M. Garnier, and C. Moore Synthetic cannabinoids in oral fluid J Anal Toxicol 35 2011 424 430
20. A.D. de Jager, J.V. Warner, M. Henman, W. Ferguson, and A. Hall LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine - an Australian perspective J Chromatogr B Analyt Technol Biomed Life Sci 897 2012 22 31
21. G. Dowling, and L. Regan A method for CP 47, 497 a synthetic non-traditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 879 2011 253 259
22. S. Dresen, N. Ferreiros, M. Putz, F. Westphal, R. Zimmermann, and V. Auwarter Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds J Mass Spectrom 45 2010 1186 1194
23. S. Dresen, S. Kneisel, W. Weinmann, R. Zimmermann, and V. Auwarter Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples J Mass Spectrom 46 2011 163 171
24. Drug Enforcement Administration, and DoJ Schedules of controlled substances: temporary placement of three synthetic cathinones in schedule I Final Order Fed Regist 76 2011 65371 65375
25. M.A. ElSohly, W. Gul, K.M. Elsohly, T.P. Murphy, V.L. Madgula, and S.I. Khan Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites J Anal Toxicol 35 2011 487 495
26. EMCDDA Understanding the 'Spice' phenomenon European Monitoring Centre for Drugs and Drug Addiction EMCDDA 2009 thematic paper 2009 Office for Official Publications of the European Communities 1 25
27. B. Emerson, B. Durham, J. Gidden, and J.O. Lay Jr. Gas chromatography-mass spectrometry of JWH-018 metabolites in urine samples with direct comparison to analytical standards Forensic Sci Int 229 2013 1 6
28. F. Fan, D.R. Compton, S. Ward, L. Melvin, and B.R. Martin Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212 J Pharmacol Exp Ther 271 1994 1383 1390 (Pubitemid 24382649)
29. W.E. Fantegrossi, K.S. Murnane, and C.J. Reissig The behavioral pharmacology of hallucinogens Biochem Pharmacol 75 2008 17 33 (Pubitemid 350235393)
30. L. Fattore, G. Cossu, C.M. Martellotta, and W. Fratta Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats Psychopharmacology (Berl) 156 2001 410 416 (Pubitemid 32695850)
31. L. Fattore, and W. Fratta Beyond THC: the new generation of cannabinoid designer drugs Front Behav Neurosci 5 2011 1 12
32. J.M. Franklin, and G.A. Carrasco G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced upregulation of serotonin 2A receptors J Biol Chem 288 2013 15712 15724
33. J.M. Franklin, T. Vasiljevik, T.E. Prisinzano, and G.A. Carrasco Cannabinoid 2 receptor- and beta arrestin 2-dependent upregulation of serotonin 2A receptors Eur Neuropsychopharmacol 23 2012 760 767
34. J.M. Frost, M.J. Dart, K.R. Tietje, T.R. Garrison, G.K. Grayson, and A.V. Daza et al. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity J Med Chem 53 2010 295 315
35. I. Gamaleddin, A. Zvonok, A. Makriyannis, S.R. Goldberg, and B. Le Foll Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking PLoS One 7 2012 e29900
36. G. Ghisleni, V. Kazlauckas, F.L. Both, N. Pagnussat, S. Mioranzza, and J.B. Rocha et al. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1508 1515
37. B.C. Ginsburg, D.R. Schulze, L. Hruba, and L.R. McMahon JWH-018 and JWH-073: delta(9)-tetrahydrocannabinol-like discriminative stimulus effects in monkeys J Pharmacol Exp Ther 340 2012 37 45
38. S. Gonzalez, M. Cebeira, and J. Fernandez-Ruiz Cannabinoid tolerance and dependence: a review of studies in laboratory animals Pharmacol Biochem Behav 81 2005 300 318 (Pubitemid 40807129)
39. R. Gottardo, A. Chiarini, I. Dal Pra, C. Seri, C. Rimondo, and G. Serpelloni et al. Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS J Mass Spectrom 47 2012 141 146
40. G. Griffin, P.J. Atkinson, V.M. Showalter, B.R. Martin, and M.E. Abood Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5′-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes J Pharmacol Exp Ther 285 1998 553 560 (Pubitemid 28237432)
41. P. Griffiths, R. Sedefov, A. Gallegos, and D. Lopez How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study Addiction 105 2010 951 953
42. A. Grigoryev, A. Melnik, S. Savchuk, A. Simonov, and V. Rozhanets Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures J Chromatogr B Analyt Technol Biomed Life Sci 879 2011 2519 2526
43. A. Grigoryev, S. Savchuk, A. Melnik, N. Moskaleva, J. Dzhurko, and M. Ershov et al. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures J Chromatogr B Analyt Technol Biomed Life Sci 879 2011 1126 1136
44. E.W. Gunderson, H.M. Haughey, N. Ait-Daoud, A.S. Joshi, and C.L. Hart "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans Am J Addict 21 2012 320 326
45. M. Haney The marijuana withdrawal syndrome: diagnosis and treatment Curr Psychiatr Rep 7 2005 360 366 (Pubitemid 41684183)
46. R.T. Harris, W. Waters, and D. McLendon Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys Psychopharmacologia 37 1974 23 29
47. J. Hirvonen, R.S. Goodwin, C.T. Li, G.E. Terry, S.S. Zoghbi, and C. Morse Reversible and regionally selective downregulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers Mol Psychiatry 17 2011 642 649
48. A.C. Howlett, T.M. Champion, G.H. Wilken, and R. Mechoulam Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor Neuropharmacol 29 1990 161 165 (Pubitemid 20059592)
49. L. Hruba, B.C. Ginsburg, and L.R. McMahon Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by delta(9)-tetrahydrocannabinol treatment in rhesus monkeys J Pharmacol Exp Ther 342 2012 843 849
50. S. Hudson, J. Ramsey, L. King, S. Timbers, S. Maynard, and P.I. Dargan et al. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products J Anal Toxicol 34 2010 252 260
51. M.A. Huestis Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol Handb Exp Pharmacol 2005 657 690
52. J.W. Huffman, and L.W. Padgett Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes Curr Med Chem 12 2005 1395 1411 (Pubitemid 40872583)
53. J.W. Huffman, P.V. Szklennik, A. Almond, K. Bushell, D.E. Selley, and H. He et al. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles Bioorg Med Chem Lett 15 2005 4110 4113 (Pubitemid 41132671)
54. J.W. Huffman, A.L. Thompson, J.L. Wiley, and B.R. Martin Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940 Bioorg Med Chem 16 2008 322 335
55. M. Hutter, S. Broecker, S. Kneisel, and V. Auwarter Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques J Mass Spectrom 47 2012 54 65
56. P. Jankovics, A. Varadi, L. Tolgyesi, S. Lohner, J. Nemeth-Palotas, and J. Balla Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl) indole in seized bulk powders in Hungary Forensic Sci Int 214 2012 27 32
57. T.U. Jarbe, H. Deng, S.K. Vadivel, and A. Makriyannis Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (delta(9)-tetrahydrocannabinol) discrimination for rats Behav Pharmacol 22 2011 498 507
58. T.U. Jarbe, R.J. Lamb, S. Lin, and A. Makriyannis (R)-methanandamide and delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide Psychopharmacology (Berl) 156 2001 369 380 (Pubitemid 32695845)
59. T.U. Jarbe, C. Li, S.K. Vadivel, and A. Makriyannis Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol Psychopharmacology (Berl) 208 2010 87 98
60. L.D. Johnston, P.M. O'malley, J.G. Bachman, and J.E. Schulenberg Marijuana use continues to rise among U.S. teens, while alcohol use hits historic lows 2011 University of Michigan News Service Ann Arbor, MI
61. Z. Justinova, M. Solinas, G. Tanda, G.H. Redhi, and S.R. Goldberg The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys J Neurosci 25 2005 5645 5650 (Pubitemid 40800656)
62. Z. Justinova, G. Tanda, G.H. Redhi, and S.R. Goldberg Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys Psychopharmacology (Berl) 169 2003 135 140 (Pubitemid 37129964)
63. Z. Justinova, S. Yasar, G.H. Redhi, and S.R. Goldberg The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys J Neurosci 31 2011 7043 7048
64. S.L. Kacinko, A. Xu, J.W. Homan, M.M. McMullin, D.M. Warrington, and B.K. Logan Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood J Anal Toxicol 35 2011 386 393
65. T. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, and N. Liang et al. The cannabinoid system and immune modulation J Leukoc Biol 74 2003 486 496 (Pubitemid 38040375)
66. S. Kneisel, V. Auwarter, and J. Kempf Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry Drug Test Anal 5 2012 657 669
67. M. Kochanowski, and M. Kala Tetrahydrocannabinols in clinical and forensic toxicology Przegl Lek 62 2005 576 580
68. J. Lapoint, L.P. James, C.L. Moran, L.S. Nelson, R.S. Hoffman, and J.H. Moran Severe toxicity following synthetic cannabinoid ingestion Clin Toxicol 49 2011 760 764
69. R. Lindigkeit, A. Boehme, I. Eiserloh, M. Luebbecke, M. Wiggermann, and L. Ernst et al. Spice: a never ending story? Forensic Sci Int 191 2009 58 63
70. P.J. Little, D.R. Compton, M.R. Johnson, L.S. Melvin, and B.R. Martin Pharmacology and stereoselectivity of structurally novel cannabinoids in mice J Pharmacol Exp Ther 247 1988 1046 1051 (Pubitemid 19022114)
71. D.P. Lovett, E.G. Yanes, T.W. Herbelin, T.A. Knoerzer, and J.A. Levisky Structure elucidation and identification of a common metabolite for naphthoylindole-based synthetic cannabinoids using LC-TOF and comparison to a synthetic reference standard Forensic Sci Int 226 2013 81 87
72. R. Maldonado Study of cannabinoid dependence in animals Pharmacol Ther 95 2002 153 164 (Pubitemid 35232133)
73. R. Maldonado, and F. Rodriguez de Fonseca Cannabinoid addiction: behavioral models and neural correlates J Neurosci 22 2002
74. R.S. Mansbach, K.L. Nicholson, B.R. Martin, and R.L. Balster Failure of delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys Behav Pharmacol 5 1994 219 225
75. M.C. Martellotta, G. Cossu, L. Fattore, G.L. Gessa, and W. Fratta Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice Neuroscience 85 1998 327 330 (Pubitemid 28218655)
76. R.P. Meyer, M. Gehlhaus, R. Knoth, and B. Volk Expression and function of cytochrome p450 in brain drug metabolism Curr Drug Metab 8 2007 297 306 (Pubitemid 46780059)
77. I. Moller, A. Wintermeyer, K. Bender, M. Jubner, A. Thomas, and O. Krug et al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls Drug Test Anal 3 2011 609 620
78. C.L. Moran, V.H. Le, K.C. Chimalakonda, A.L. Smedley, F.D. Lackey, and S.N. Owen et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine Anal Chem 83 2011 4228 4236
79. J.H. Moran Smart resource allocation needed to study 'legal highs' Nat Med 17 2011 1339
80. D. Morgan, K. Kondabolu, A. Kuipers, R. Sakhuja, K.L. Robertson, and N.E. Rowland Molecular and behavioral pharmacology of two novel orally-active 5HT2 modulators: potential utility as antipsychotic medications Neuropharmacol 72 2013 274 281
81. N. Nacca, D. Vatti, R. Sullivan, P. Sud, M. Su, and J. Marraffa The synthetic cannabinoid withdrawal syndrome J Addict Med 7 2013 296 298
82. M. Navarro, M.R. Carrera, W. Fratta, O. Valverde, G. Cossu, and L. Fattore et al. Functional interaction between opioid and cannabinoid receptors in drug self-administration J Neurosci 21 2001 5344 5350 (Pubitemid 32622960)
83. R.R. Neubig, M. Spedding, T. Kenakin, and A. Christopoulos International Union of Pharmacology Committee on Receptor N, Drug C. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology Pharmacol Rev 55 2003 597 606 (Pubitemid 37500521)
84. J.M. Oliva, S. Ortiz, T. Palomo, and J. Manzanares Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice J Neurochem 85 2003 94 104 (Pubitemid 36389699)
85. E.S. Onaivi, H. Ishiguro, J.P. Gong, S. Patel, P.A. Meozzi, and L. Myers et al. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects PLoS One 3 2008 e1640
86. M.F. Paine, H.L. Hart, S.S. Ludington, R.L. Haining, A.E. Rettie, and D.C. Zeldin The human intestinal cytochrome P450 "pie" Drug Metab Dispos 34 2006 880 886
87. C.A. Paronis, S.P. Nikas, V.G. Shukla, and A. Makriyannis Delta(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice Behav Pharmacol 23 2012 802 805
88. K.D. Patel, J.S. Davison, Q.J. Pittman, and K.A. Sharkey Cannabinoid CB(2) receptors in health and disease Curr Med Chem 17 2010 1393 1410
89. A.L. Patton, K.C. Chimalakonda, C.L. Moran, K.R. McCain, A. Radominska-Pandya, and L.P. James K2 Toxicity: fatal case of psychiatric complications following AM2201 exposure J Forensic Sci 2013 Jul 3 10.1111/1556-4029.12216 [Epub ahead of print]
90. S. Pavanello, U. Fedeli, G. Mastrangelo, F. Rota, K. Overvad, and O. Raaschou-Nielsen et al. Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study Cancer Genet 205 2012 278 284
91. B.C. Presley, S.A. Janse-Carnum, and B.K. Logan Analysis of synthetic cannabinoids in botanical material: a review of analytical method and findings Forensic Sci Rev 25 2013 27 46
92. M. Rajasekaran, L.K. Brents, L.N. Franks, J.H. Moran, and P.L. Prather Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors Toxicol Appl Pharmacol 269 2013 100 108
93. SDAPA. (Synthetic Drug Abuse Prevention Act). In: Justic Do, editor. XI2012.
94. K.A. Seely, L.K. Brents, A. Radominska-Pandya, G.W. Endres, G.S. Keyes, and J.H. Moran et al. A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors Chem Res Toxicol 25 2012 825 827
95. K.A. Seely, J. Lapoint, J.H. Moran, and L. Fattore Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids Prog Neuropsychopharmacol Biol Psychiatry 39 2012 234 243
96. K.A. Seely, P.L. Prather, L.P. James, and J.H. Moran Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Mol Interv 11 2011 36 51
97. L.J. Sim-Selley, and B.R. Martin Effect of chronic administration of R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1, 4-benzoxaz inyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice J Pharmacol Exp Ther 303 2002 36 44
98. T. Sobolevsky, I. Prasolov, and G. Rodchenkov Detection of JWH-018 metabolites in smoking mixture post-administration urine Forensic Sci Int 200 2010 141 147
99. T. Sobolevsky, I. Prasolov, and G. Rodchenkov Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids Drug Test Anal 2012 Oct 5 10.1002/dta.1418 [Epub ahead of print]
100. G. Tanda, P. Munzar, and S.R. Goldberg Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys Nat Neurosci 3 2000 1073 1074
101. J. Teske, J.P. Weller, A. Fieguth, T. Rothamel, Y. Schulz, and H.D. Troger Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 878 2010 2659 2663
102. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, and Y. Goda URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products Forensic Sci Int 227 2013 21 32
103. J.M. Van Ree, J.L. Slangen, and D. de Wied Intravenous self-administration of drugs in rats J Pharmacol Exp Ther 204 1978 547 557 (Pubitemid 8329258)
104. R. Vandrey, K.E. Dunn, J.A. Fry, and E.R. Girling A survey study to characterize use of Spice products (synthetic cannabinoids) Drug Alcohol Depend 120 2012 238 241
105. I. Vardakou, C. Pistos, and C. Spiliopoulou Spice drugs as a new trend: mode of action, identification and legislation Toxicol Lett 197 2010 157 162
106. K. Watanabe, T. Matsunaga, I. Yamamoto, Y. Funae, and H. Yoshimura Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman Biol Pharm Bull 18 1995 1138 1141
107. K. Watanabe, S. Yamaori, T. Funahashi, T. Kimura, and I. Yamamoto Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes Life Sci 80 2007 1415 1419 (Pubitemid 46367067)
108. J.M. Wiebelhaus, J.L. Poklis, A. Poklis, R.E. Vann, A.H. Lichtman, and L.E. Wise Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice Drug Alcohol Depend 126 2012 316 323
109. J.L. Wiley, J.W. Huffman, R.L. Balster, and B.R. Martin Pharmacological specificity of the discriminative stimulus effects of delta 9- tetrahydrocannabinol in rhesus monkeys Drug Alcohol Depend 40 1995 81 86
110. A. Wintermeyer, I. Moller, M. Thevis, M. Jubner, J. Beike, and M.A. Rothschild In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal Bioanal Chem 398 2010 2141 2153
111. A. Wohlfarth, K.B. Scheidweiler, X. Chen, H.F. Liu, and M.A. Huestis Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search Anal Chem 85 2013 3730 3738
112. Z.X. Xi, X.Q. Peng, X. Li, R. Song, H.Y. Zhang, and Q.R. Liu et al. Brain cannabinoid CB receptors modulate cocaine's actions in mice Nat Neurosci 14 2011 1160 1166
113. I. Yamamoto, K. Watanabe, K. Kuzuoka, S. Narimatsu, and H. Yoshimura The pharmacological activity of cannabinol and its major metabolite, 11-hydroxycannabinol Chem Pharm Bull (Tokyo) 35 1987 2144 2147
114. Q. Zhang, P. Ma, R.B. Cole, and G. Wang Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS Anal Bioanal Chem 386 2006 1345 1355 (Pubitemid 44657764)
115. Q. Zhang, P. Ma, M. Iszard, R.B. Cole, W. Wang, and G. Wang In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist Drug Metab Dispos 30 2002 1077 1086
116. Q. Zhang, P. Ma, W. Wang, R.B. Cole, and G. Wang Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry J Mass Spectrom 39 2004 672 681 (Pubitemid 38878324)
117. U.S. Zimmermann, P.R. Winkelmann, M. Pilhatsch, J.A. Nees, R. Spanagel, and K. Schulz Withdrawal phenomena and dependence syndrome after the consumption of "spice gold" Dtsch Arztebl Int 106 2009 464 467
118. D. Zuba, B. Byrska, and M. Maciow Comparison of "herbal highs" composition Anal Bioanal Chem 400 2011 119 126